[Form 4] Palisade Bio, Inc. Insider Trading Activity
Palisade Bio director Donald Allen received a grant of 64,400 phantom units on 09/04/2025. Each phantom unit represents the economic equivalent of one share of Palisade Bio common stock. The award vests in three equal annual installments beginning August 5, 2026, provided the reporting person remains in continuous service through each vesting date. Vested phantom units will be settled solely in cash based on the fair market value of an equal number of shares upon termination of service, a liquidity change in control, or the seventh anniversary of the grant. The reporting person鈥檚 ownership after the grant is 64,400 common stock equivalents, held directly.
Il direttore di Palisade Bio, Donald Allen, ha ricevuto un premio di 64.400 unit脿 fantasma il 09/04/2025. Ciascuna unit脿 fantasma rappresenta l'equivalente economico di una azione ordinaria di Palisade Bio. Il premio matura in tre quote annuali uguali a partire dal 5 agosto 2026, a condizione che la persona segnalante rimanga in servizio continuativo fino a ciascuna data di maturazione. Le unit脿 fantasma maturate saranno liquidate esclusivamente in contanti in base al valore di mercato equo di un numero equivalente di azioni al momento della cessazione del servizio, di una modifica di controllo con liquidit脿 o al settimo anniversario della concessione. La partecipazione della persona segnalante dopo la concessione 猫 di 64.400 equivalenti in azioni ordinarie, detenuti direttamente.
El director de Palisade Bio, Donald Allen, recibi贸 una concesi贸n de 64.400 unidades fantasma el 09/04/2025. Cada unidad fantasma representa el equivalente econ贸mico de una acci贸n ordinaria de Palisade Bio. La adjudicaci贸n se consolida en tres cuotas anuales iguales a partir del 5 de agosto de 2026, siempre que la persona informante permanezca en servicio continuo hasta cada fecha de consolidaci贸n. Las unidades fantasma consolidadas se liquidar谩n 煤nicamente en efectivo, bas谩ndose en el valor razonable de mercado de un n煤mero equivalente de acciones al t茅rmino del servicio, en un cambio de control con liquidez o en el s茅ptimo aniversario de la concesi贸n. La propiedad de la persona informante tras la concesi贸n es de 64.400 equivalentes de acciones ordinarias, mantenidos directamente.
Palisade Bio鞚� 鞚挫偓 Donald Allen鞚� 2025雲� 09鞗� 04鞚检棎 64,400臧滌潣 韺厐 鞙犽嫑鞚� 攵�鞐皼鞎橃姷雼堧嫟. 臧� 韺厐 鞙犽嫑鞚� Palisade Bio 氤错喌欤� 1欤检檧 霃欖澕頃� 瓴届牅鞝� 臧�旃橂ゼ 雮橅儉雰呺媹雼�. 頃措嫻 靸侅棳電� 2026雲� 8鞗� 5鞚茧秬韯� 鞁滌瀾頃橃棳 毵る厔 霃欖澕頃� 3須� 攵勴暊搿� 氩犾姢韺呺悩氅�, 氤搓碃鞚�(氤搓碃鞛�)鞚� 臧� 氩犾姢韺呾澕鞐� 瓯胳硱 瓿勳啀 攴茧 欷戩澑 瓴届毎鞐愲 鞙犿毃頃╇媹雼�. 氩犾姢韺呺悳 韺厐 鞙犽嫑鞚� 攴茧 膦呺 鞁�, 鞙犽彊靹� 鞛堧姅 鞚胳垬路頃╇硲(氤�霃欕悳 歆�氚瓣惮臁�) 鞁� 霕愲姅 攵�鞐澕搿滊秬韯� 7欤茧厔 鞁滌爯鞐� 霃欖垬鞚� 欤检嫕鞐� 頃措嫻頃橂姅 瓿奠爼鞁滌灔臧�旃橂ゼ 旮办鞙茧 順勱笀鞙茧毵� 鞝曥偘霅╇媹雼�. 攵�鞐� 頉� 氤搓碃鞚胳潣 氤挫湢電� 歆侅爲 氤挫湢頃� 64,400欤检潣 氤错喌欤� 霌标皜鞛呺媹雼�.
Le directeur de Palisade Bio, Donald Allen, a re莽u une attribution de 64 400 unit茅s fant么mes le 04/09/2025. Chaque unit茅 fant么me repr茅sente l'茅quivalent 茅conomique d'une action ordinaire de Palisade Bio. L'attribution acquiert droit par trois versements annuels 茅gaux 脿 compter du 5 ao没t 2026, sous r茅serve que la personne d茅clarante demeure en service continu jusqu'脿 chaque date d'acquisition des droits. Les unit茅s fant么mes acquises seront r茅gl茅es uniquement en esp猫ces, sur la base de la juste valeur marchande d'un nombre 茅quivalent d'actions lors de la cessation de service, d'un changement de contr么le entra卯nant une liquidit茅, ou au septi猫me anniversaire de l'attribution. La d茅tention de la personne d茅clarante apr猫s l'attribution est de 64 400 茅quivalents en actions ordinaires, d茅tenus directement.
Palisade Bio-Direktor Donald Allen erhielt am 04.09.2025 einen Zuschuss von 64.400 Phantom-Einheiten. Jede Phantom-Einheit stellt das wirtschaftliche 脛quivalent einer Aktie der Palisade Bio-Stammaktie dar. Die Zuteilung wird in drei gleichen j盲hrlichen Raten ab dem 5. August 2026 f盲llig, vorausgesetzt, die meldepflichtige Person bleibt bis zu jedem Vesting-Termin ununterbrochen im Dienst. Durch Vesting entstandene Phantom-Einheiten werden ausschlie脽lich in bar beglichen, und zwar auf Basis des Marktwertes derselben Anzahl von Aktien bei Dienstende, bei einem Liquidit盲ts-bezogenen Kontrollwechsel oder am siebten Jahrestag der Gew盲hrung. Der Besitz der meldepflichtigen Person nach der Gew盲hrung betr盲gt 64.400 Stammaktien盲quivalente, direkt gehalten.
- Grant disclosed clearly: 64,400 phantom units awarded to director, with explicit vesting schedule and settlement terms
- Retention structure: Vesting in three equal annual installments beginning 08/05/2026 supports director continuity
- Cash settlement obligation: Vested phantom units are settled solely in cash, creating potential future cash liabilities for the company
- Timing risk: Vesting begins nearly a year after grant, delaying realization and potentially concentrating cash payouts in future periods
Insights
TL;DR: Director grant of cash-settled phantom units is a standard retention tool but creates a future cash obligation for the company.
The form shows a 09/04/2025 grant of 64,400 phantom units to a director, vesting in three equal annual installments starting 08/05/2026, contingent on continuous service. These units are cash-settled on vesting or certain triggering events, which creates a potential future cash liability rather than equity dilution. For governance review, key considerations include the size of the grant relative to other director compensation, the cash funding plan for settlements, and whether vesting terms align with shareholder interests. This disclosure is routine but material to assessing near-term cash obligations tied to executive/director compensation.
TL;DR: A sizeable phantom unit award for a director provides retention incentives but shifts payout risk to the company as cash settlements.
The reporting person beneficially owns 64,400 phantom units representing equivalent common shares. Vesting across three annual tranches beginning 08/05/2026 conditions retention. Settlement is expressly cash-only upon vesting or specified events, meaning the company will pay the fair market value in cash rather than issue shares. This affects cash flow planning and compensation expense recognition under accounting rules. The disclosure is specific and standard for non-qualified, cash-settled awards.
Il direttore di Palisade Bio, Donald Allen, ha ricevuto un premio di 64.400 unit脿 fantasma il 09/04/2025. Ciascuna unit脿 fantasma rappresenta l'equivalente economico di una azione ordinaria di Palisade Bio. Il premio matura in tre quote annuali uguali a partire dal 5 agosto 2026, a condizione che la persona segnalante rimanga in servizio continuativo fino a ciascuna data di maturazione. Le unit脿 fantasma maturate saranno liquidate esclusivamente in contanti in base al valore di mercato equo di un numero equivalente di azioni al momento della cessazione del servizio, di una modifica di controllo con liquidit脿 o al settimo anniversario della concessione. La partecipazione della persona segnalante dopo la concessione 猫 di 64.400 equivalenti in azioni ordinarie, detenuti direttamente.
El director de Palisade Bio, Donald Allen, recibi贸 una concesi贸n de 64.400 unidades fantasma el 09/04/2025. Cada unidad fantasma representa el equivalente econ贸mico de una acci贸n ordinaria de Palisade Bio. La adjudicaci贸n se consolida en tres cuotas anuales iguales a partir del 5 de agosto de 2026, siempre que la persona informante permanezca en servicio continuo hasta cada fecha de consolidaci贸n. Las unidades fantasma consolidadas se liquidar谩n 煤nicamente en efectivo, bas谩ndose en el valor razonable de mercado de un n煤mero equivalente de acciones al t茅rmino del servicio, en un cambio de control con liquidez o en el s茅ptimo aniversario de la concesi贸n. La propiedad de la persona informante tras la concesi贸n es de 64.400 equivalentes de acciones ordinarias, mantenidos directamente.
Palisade Bio鞚� 鞚挫偓 Donald Allen鞚� 2025雲� 09鞗� 04鞚检棎 64,400臧滌潣 韺厐 鞙犽嫑鞚� 攵�鞐皼鞎橃姷雼堧嫟. 臧� 韺厐 鞙犽嫑鞚� Palisade Bio 氤错喌欤� 1欤检檧 霃欖澕頃� 瓴届牅鞝� 臧�旃橂ゼ 雮橅儉雰呺媹雼�. 頃措嫻 靸侅棳電� 2026雲� 8鞗� 5鞚茧秬韯� 鞁滌瀾頃橃棳 毵る厔 霃欖澕頃� 3須� 攵勴暊搿� 氩犾姢韺呺悩氅�, 氤搓碃鞚�(氤搓碃鞛�)鞚� 臧� 氩犾姢韺呾澕鞐� 瓯胳硱 瓿勳啀 攴茧 欷戩澑 瓴届毎鞐愲 鞙犿毃頃╇媹雼�. 氩犾姢韺呺悳 韺厐 鞙犽嫑鞚� 攴茧 膦呺 鞁�, 鞙犽彊靹� 鞛堧姅 鞚胳垬路頃╇硲(氤�霃欕悳 歆�氚瓣惮臁�) 鞁� 霕愲姅 攵�鞐澕搿滊秬韯� 7欤茧厔 鞁滌爯鞐� 霃欖垬鞚� 欤检嫕鞐� 頃措嫻頃橂姅 瓿奠爼鞁滌灔臧�旃橂ゼ 旮办鞙茧 順勱笀鞙茧毵� 鞝曥偘霅╇媹雼�. 攵�鞐� 頉� 氤搓碃鞚胳潣 氤挫湢電� 歆侅爲 氤挫湢頃� 64,400欤检潣 氤错喌欤� 霌标皜鞛呺媹雼�.
Le directeur de Palisade Bio, Donald Allen, a re莽u une attribution de 64 400 unit茅s fant么mes le 04/09/2025. Chaque unit茅 fant么me repr茅sente l'茅quivalent 茅conomique d'une action ordinaire de Palisade Bio. L'attribution acquiert droit par trois versements annuels 茅gaux 脿 compter du 5 ao没t 2026, sous r茅serve que la personne d茅clarante demeure en service continu jusqu'脿 chaque date d'acquisition des droits. Les unit茅s fant么mes acquises seront r茅gl茅es uniquement en esp猫ces, sur la base de la juste valeur marchande d'un nombre 茅quivalent d'actions lors de la cessation de service, d'un changement de contr么le entra卯nant une liquidit茅, ou au septi猫me anniversaire de l'attribution. La d茅tention de la personne d茅clarante apr猫s l'attribution est de 64 400 茅quivalents en actions ordinaires, d茅tenus directement.
Palisade Bio-Direktor Donald Allen erhielt am 04.09.2025 einen Zuschuss von 64.400 Phantom-Einheiten. Jede Phantom-Einheit stellt das wirtschaftliche 脛quivalent einer Aktie der Palisade Bio-Stammaktie dar. Die Zuteilung wird in drei gleichen j盲hrlichen Raten ab dem 5. August 2026 f盲llig, vorausgesetzt, die meldepflichtige Person bleibt bis zu jedem Vesting-Termin ununterbrochen im Dienst. Durch Vesting entstandene Phantom-Einheiten werden ausschlie脽lich in bar beglichen, und zwar auf Basis des Marktwertes derselben Anzahl von Aktien bei Dienstende, bei einem Liquidit盲ts-bezogenen Kontrollwechsel oder am siebten Jahrestag der Gew盲hrung. Der Besitz der meldepflichtigen Person nach der Gew盲hrung betr盲gt 64.400 Stammaktien盲quivalente, direkt gehalten.
FAQ
What did PALI director Donald Allen receive on 09/04/2025?
When do the phantom units vest for the PALI grant?
How are vested phantom units settled according to the Form 4?
How many common stock equivalents does the reporting person beneficially own after this transaction?
Is the Form 4 filing individual or joint for this transaction?
